LUANN HARRIS: Open Payments
NPI 1235134883 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 25 payments from 14 companies in 2025. Trend: 2023 $845 · 2024 $895 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $187 |
| Genmab U.S., Inc. | 1 | $122 |
| ABBVIE INC. | 3 | $69 |
| Lilly USA, LLC | 3 | $62 |
| Daiichi Sankyo Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Janssen Biotech, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| TAIHO ONCOLOGY, INC. | 1 | $24 |
| PharmaEssentia USA Corporation | 1 | $22 |
Products named: Trodelvy, Epkinly, ENHERTU, VERZENIO, ELAHERE, OPDIVO, RYBREVANT, SCEMBLIX.
Industry payments across SC — which companies pay providers there.
